Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
1.935
-0.045 (-2.27%)
Mar 6, 2026, 2:55 PM EST - Market open
ENVB's stock price has decreased by -92.16% in the past year and price targets may not have had time to catch up.
Enveric Biosciences Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$120.00
Upside
+6,101.55%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $120 | Strong Buy | Reiterates | $120 | +6,101.55% | Mar 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $1,800 | Strong Buy | Initiates | $1,800 | +92,923.26% | Jan 30, 2024 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $11,250 | Strong Buy | Initiates | $11,250 | +581,295.35% | Jun 1, 2022 |
| Aegis Capital | Aegis Capital | Strong Buy → Hold Downgrades $63,000 → $1,800 | Strong Buy → Hold | Downgrades | $63,000 → $1,800 | +92,923.26% | Mar 8, 2022 |
| Aegis Capital | Aegis Capital | Strong Buy Initiates $63,000 | Strong Buy | Initiates | $63,000 | +3,255,713.95% | Jul 8, 2021 |
| Maxim Group | Maxim Group | Strong Buy Initiates $54,000 | Strong Buy | Initiates | $54,000 | +2,790,597.67% | Jun 28, 2021 |